QUESTIONS PATIENTS
SHOULD ASK
The most important questions for CAR-T consultations β framed the way they actually land in real conversations with oncologists.
Be Your Own Best Advocate
Asking specific, informed questions changes the quality of the conversation. Patients who arrive prepared get more complete answers, better understanding of reasoning, and a clearer picture of what to expect.
Questions About Eligibility & Product Selection
Why is CAR-T being recommended now?
Understand the timing rationale β why not earlier, why not later in your treatment history.
Which specific product is proposed, and why?
Different products have different evidence bases, toxicity profiles, and manufacturing timelines.
Has antigen expression been confirmed?
The product needs a target. Testing should confirm your tumour expresses it.
What's the contingency if manufacturing fails?
5-10% of manufacturing attempts don't pass quality control. What happens then?
Questions About Outcomes & Centre Experience
How many CAR-T infusions does your centre perform annually?
Centre volume correlates with experience and outcomes.
What are your Grade 3-4 CRS and ICANS rates?
Centre-specific data may differ from published trial averages.
What is the CR rate for my specific cancer subtype?
Ask for data specific to your situation, not headline averages.
If I respond but then relapse, what options exist?
Understanding the next step matters even before starting.
Questions About Logistics & Support
Timeline
How long from leukapheresis to end of monitoring? When can I travel home?
Accommodation
What support exists for patients who've travelled? What about caregivers?
Second Opinion
Would a second opinion at another high-volume centre change the approach? Is there benefit to treating at a higher-volume centre?
Frequently Asked Questions
About Consultations
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination β travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Preparing for a CAR-T Consultation?
Upload your reports for a specialist case evaluation. We help you understand which questions matter most for your specific situation.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.